Beneficial Effects of Adjusted Perfusion and Defibrillation Strategies on Rhythm Control within Controlled Automated Reperfusion of the Whole Body (CARL) for Refractory Out-of-Hospital Cardiac Arrest
- PMID: 35456204
- PMCID: PMC9031732
- DOI: 10.3390/jcm11082111
Beneficial Effects of Adjusted Perfusion and Defibrillation Strategies on Rhythm Control within Controlled Automated Reperfusion of the Whole Body (CARL) for Refractory Out-of-Hospital Cardiac Arrest
Abstract
Survival and neurological outcomes after out-of-hospital cardiac arrest (OHCA) remain low. The further development of prehospital extracorporeal resuscitation (ECPR) towards Controlled Automated Reperfusion of the Whole Body (CARL) has the potential to improve survival and outcome in these patients. In CARL therapy, pulsatile, high blood-flow reperfusion is performed combined with several modified reperfusion parameters and adjusted defibrillation strategies. We aimed to investigate whether pulsatile, high-flow reperfusion is feasible in refractory OHCA and whether the CARL approach improves heart-rhythm control during ECPR. In a reality-based porcine model of refractory OHCA, 20 pigs underwent prehospital CARL or conventional ECPR. Significantly higher pulsatile blood-flow proved to be feasible, and critical hypotension was consistently prevented via CARL. In the CARL group, spontaneous rhythm conversions were observed using a modified priming solution. Applying potassium-induced secondary cardioplegia proved to be a safe and effective method for sustained rhythm conversion. Moreover, significantly fewer defibrillation attempts were needed, and cardiac arrhythmias were reduced during reperfusion via CARL. Prehospital CARL therapy thus not only proved to be feasible after prolonged OHCA, but it turned out to be superior to conventional ECPR regarding rhythm control.
Keywords: cardiopulmonary resuscitation; extracorporeal circulation; post-resuscitation care.
Conflict of interest statement
F.B., C.B. and G.T. are shareholders in Resuscitec GmbH, Freiburg, Germany, which is a start-up company of the University Medical Centre Freiburg. J.-S.P., S.J.B., P.G., D.D. and C.S. are part-time employees of Resuscitec GmbH, Freiburg, Germany. The remaining authors have disclosed that they have no conflicts of interest to declare.
Figures
References
-
- Gräsner J.-T., Lefering R., Koster R.W., Masterson S., Böttiger B.W., Herlitz J., Wnent J., Tjelmeland I.B.M., Ortiz F.R., Maurer H., et al. EuReCa ONE-27 Nations, ONE Europe, ONE Registry: A Prospective One Month Analysis of out-of-Hospital Cardiac Arrest Outcomes in 27 Countries in Europe. Resuscitation. 2016;105:188–195. doi: 10.1016/j.resuscitation.2016.06.004. - DOI - PubMed
-
- Fischer M., Wnent J., Gräsner J.-T., Seewald S., Brenner S., Bein B., Ristau P., Bohn A. Die teilnehmenden Rettungsdienste am Deut- schen Reanimationsregister Öffentlicher Jahresbericht 2020 Des Deutschen Reanimationsregisters: Außerklinische Reanimation 2020. 2020. [(accessed on 12 January 2022)]. Available online: https://www.reanimationsregister.de/downloads.
-
- Gräsner J.-T., Wnent J., Herlitz J., Perkins G.D., Lefering R., Tjelmeland I., Koster R.W., Masterson S., Rossell-Ortiz F., Maurer H., et al. Survival after Out-of-Hospital Cardiac Arrest in Europe—Results of the EuReCa TWO Study. Resuscitation. 2020;148:218–226. doi: 10.1016/j.resuscitation.2019.12.042. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
